Background: Vascular endothelial growth factor (VEGF; vascular permeability
factor) is one of the most potent proangiogenic cytokines, and it plays a
central role in mediating the process of angiogenesis or new blood vessel f
ormation. Neutrophils (PMNs) recently have been shown to produce VEGF.
Hypothesis: The acute inflammatory response is a potent stimulus for PMN-di
rected angiogenesis.
Methods: Neutrophils were isolated from healthy volunteers and stimulated w
ith lipopolysaccharide (LPS), tumor necrosis factor alpha (TNF-alpha), inte
rleukin 6 (IL-6), and anti-human Fas monoclonal antibody. Culture supernata
nts were assayed for VEGF using enzyme-linked immunosorbent assays. Culture
supernatants from LPS- and TNF-alpha-stimulated PMNs were then added to hu
man umbilical vein endothelial cells and human microvessel endothelial cell
s and assessed for endothelial cell proliferation using 5-bromodeoxyuridine
labeling. Tubule formation was also assessed on MATRIGEL basement membrane
matrix. Neutrophils were lysed to measure total VEGF release, and VEGF exp
ression was detected using Western blot analysis.
Results: Lipopolysaccharide and TNF-alpha stimulation resulted in significa
ntly increased release of PMN VEGF (532 +/- 49 and 484 +/- 80 pg/mL, respec
tively; for all, presented as mean +/- SEM) compared with control experimen
ts (32 +/- 4 pg/mL). Interleukin 6 and Fas had no effect. Culture supernata
nts from LPS- and TNF-alpha-stimulated PMNs also resulted in significant in
creases (P<.005) in macrovascular and microvascular endothelial cell prolif
eration and tubule formation. Adding anti-human VEGF-neutralizing polyclona
l antibody to stimulated PMN supernatant inhibited these effects. Total VEG
F release following cell lysis and Western blot analysis suggests that the
VEGF is released from an intracellular store.
Conclusion: Activated human PMNs are directly angiogenic by releasing VEGF,
and this has important implications for inflammation, capillary leak syndr
ome, wound healing, and tumor growth.